Clinical Trial Update: Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction chemotherapy with nimotuzumab in locally advanced head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Fudan University | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED